CompaniesAlpha-9 Oncology

Alpha-9 Oncology

active

Vancouver, BC, Canada

Founded 2018

About

Radiopharmaceuticals

Areas of Focus

Categories

Radiopharmaceuticals

Team (23)

Alison Fleming, PhD

Alpha-9 Oncology

Andrei Iagaru, MD

Alpha-9 Oncology

Darcy Mootz, PhD

Alpha-9 Oncology

David Hirsch, MD, PhD

Alpha-9 Oncology

David Perrin, PhD

Alpha-9 Oncology

Evan Rachlin, MD

Alpha-9 Oncology

View all 23 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

50

By Phase

PHASE1: 1

By Status

NOT_YET_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

2028

2029

Today

Hover over trial bars to see details

Recent Trials

NCT07076550Lead Sponsor

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

PHASE1Not yet recruiting

50 participants

Started: Aug 31, 2025 · Completed: Jan 31, 2028

Locations (1)

Headquarters

Vancouver, BC, Canada

Map

Loading map...